Biological E to make 50 million doses of Takeda's dengue vaccine QDENGA
India Business News: Takeda and Biological E Limited have partnered to manufacture up to 50 million doses per year of the dengue vaccine QDENGA, with the goal of deliverin
Stay updated with breaking news from Biological E. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
India Business News: Takeda and Biological E Limited have partnered to manufacture up to 50 million doses per year of the dengue vaccine QDENGA, with the goal of deliverin
India Business News: Biological E's Covid-19 vaccine CORBEVAX has received emergency use listing from the World Health Organisation (WHO). The vaccine was approved in India for restricted use in emergency for adults, adolescents, and young children, as well as a heterologous booster dose for those aged 18 years and above. The Hyderabad-based vaccine maker has already supplied 100 million doses of CORBEVAX to the Indian government. The WHO EUL will help the company continue developing Covid-19 vaccines.
India News: Biological E's Covid vaccine, Corbevax, has received WHO emergency use listing, following approval in India. The vaccine, developed on the protein sub
Describing the murder of a 16-year-old girl by 23-year-old Sahil Khan as "premeditated" and "planned revenge", Delhi Police has filed a 640-page charg
Ranchi: A batch of 95 officials from police, child welfare committees and non-government organisations are undergoing training at the Investigation Tr.